{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T21:28:33Z","timestamp":1789939713567,"version":"4.0.1"},"reference-count":119,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T00:00:00Z","timestamp":1533254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NICHD HD061959"],"award-info":[{"award-number":["NICHD HD061959"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Congenital human cytomegalovirus (HCMV) is the most common viral infection of the developing fetus, and a significant cause of neurodevelopmental abnormalities in infants and children. Congenital HCMV infections account for an estimated 25% of all cases of hearing loss in the US. It has long been argued that maternal adaptive immune responses to HCMV can modify both the likelihood of intrauterine transmission of HCMV, and the severity of fetal infection and risk of long term sequelae in infected infants. Over the last two decades, multiple studies have challenged this paradigm, including findings that have demonstrated that the vast majority of infants with congenital HCMV infections in most populations are born to women with established immunity prior to conception. Furthermore, the incidence of clinically apparent congenital HCMV infection in infants born to immune and non-immune pregnant women appears to be similar. These findings from natural history studies have important implications for the design, development, and testing of prophylactic vaccines and biologics for this perinatal infection. This brief overview will provide a discussion of existing data from human natural history studies and animal models of congenital HCMV infections that have described the role of maternal immunity in the natural history of this perinatal infection.<\/jats:p>","DOI":"10.3390\/v10080405","type":"journal-article","created":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T11:03:26Z","timestamp":1533294206000},"page":"405","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":99,"title":["Maternal Immunity and the Natural History of Congenital Human Cytomegalovirus Infection"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6257-1541","authenticated-orcid":false,"given":"William J.","family":"Britt","sequence":"first","affiliation":[{"name":"Departments of Pediatrics, Microbiology, and Neurobiology, University of Alabama School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,8,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1056\/NEJMoa1006561","article-title":"Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns","volume":"364","author":"Boppana","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1086\/600882","article-title":"Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population","volume":"49","author":"Yamamoto","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/CMR.00062-12","article-title":"The \u201csilent\u201d global burden of congenital cytomegalovirus","volume":"26","author":"Manicklal","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/rmv.535","article-title":"Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection","volume":"17","author":"Kenneson","year":"2007","journal-title":"Rev. Med. Virol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/INF.0000000000000555","article-title":"Prevalence of congenital cytomegalovirus infection in Nigeria: A pilot study","volume":"34","author":"Olusanya","year":"2015","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Barbosa, N.G., Yamamoto, A.Y., Duarte, G., Aragon, D.C., Fowler, K.B., Boppana, S., Britt, W.J., and Mussi-Pinhata, M.M. (2018). Cytomegalovirus (CMV) Shedding in Seropositive Pregnant Women from a High Seroprevalence Population: \u201cThe Brazilian Cytomegalovirus Hearing and Maternal Secondary Infection Study\u201d (BraCHS). Clin. Infect. Dis.","DOI":"10.1093\/cid\/ciy166"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Fowler, K.B., Ross, S.A., Shimamura, M., Ahmed, A., Palmer, A.L., Michaels, M.G., Bernstein, D.I., Sanchez, P.J., Feja, K.N., and Stewart, A. (2018). Racial and Ethnic Differences in the Prevalence of Congenital Cytomegalovirus Infection. J. Pediatr.","DOI":"10.1016\/j.jpeds.2018.04.043"},{"key":"ref_8","first-page":"87","article-title":"Chronic congenital infections: Common environmental causes for severe and subtle birth defects","volume":"19","author":"Alford","year":"1983","journal-title":"Birth Defects Orig. Artic. Ser."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00430-015-0399-9","article-title":"Controversies in the natural history of congenital human cytomegalovirus infection: The paradox of infection and disease in offspring of women with immunity prior to pregnancy","volume":"204","author":"Britt","year":"2015","journal-title":"Med. Microbiol. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/ije\/28.6.1176","article-title":"Modelling the incidence of congenital rubella syndrome in developing countries","volume":"28","author":"Cutts","year":"1999","journal-title":"Int. J. Epidemiol."},{"key":"ref_11","unstructured":"Remington, J.S., and Klein, J.O. (1995). Infectious Diseases of the Fetus and Newborn Infant, WB Saunders. [4th ed.]."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Netto, E.M., Moreira-Soto, A., Pedroso, C., H\u00f6ser, C., Funk, S., Kucharski, A.J., Rockstroh, A., K\u00fcmmerer, B.M., Sampaio, G.S., and Luz, E. (2017). High Zika Virus Seroprevalence in Salvador, Northeastern Brazil Limits the Potential for Further Outbreaks. mBio, 8.","DOI":"10.1128\/mBio.01390-17"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/jmv.1890130405","article-title":"Factors associated with primary cytomegalovirus infection during pregnancy","volume":"13","author":"Stagno","year":"1984","journal-title":"J. Med. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/infdis\/168.3.552","article-title":"Maternal age and congenital cytomegalovirus infection: Screening of two diverse newborn populations, 1980\u20131990","volume":"168","author":"Fowler","year":"1993","journal-title":"J. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jcv.2008.07.012","article-title":"Cytomegalovirus seroprevalence and childhood sources of infection: A population-based study among pre-adolescents in the United States","volume":"43","author":"Staras","year":"2008","journal-title":"J. Clin. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/infdis\/143.2.188","article-title":"Prevalence of cytomegalovirus infection in homosexual men","volume":"143","author":"Drew","year":"1981","journal-title":"J. Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/infdis\/171.1.33","article-title":"Cervical but not urinary excretion of cytomegalovirus is related to sexual activity and contraceptive practices in sexually active women","volume":"171","author":"Collier","year":"1995","journal-title":"J. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/infdis\/152.3.597","article-title":"The epidemiology of cytomegaloviral infection in women attending a sexually transmitted disease clinic","volume":"152","author":"Chandler","year":"1985","journal-title":"J. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Remis, R.S., Liu, J., Loutfy, M.R., Tharao, W., Rebbapragada, A., Huibner, S., Kesler, M., Halpenny, R., Grennan, T., and Brunetta, J. (2016). Prevalence of Sexually Transmitted Viral and Bacterial Infections in HIV-Positive and HIV-Negative Men Who Have Sex with Men in Toronto. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0158090"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jpeds.2013.12.007","article-title":"Spectrum of Disease and Outcome in Children with Symptomatic Congenital Cytomegalovirus Infection","volume":"164","author":"Dreher","year":"2014","journal-title":"J. Pediatr."},{"key":"ref_21","first-page":"1","article-title":"Synopsis of clinical aspects of human cytomegalovirus disease","volume":"Volume 2","author":"Reddehase","year":"2013","journal-title":"Cytomegaloviruses: From Molecular Pathogenesis to Intervention"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Britt, W.J. (2017). Congenital Human Cytomegalovirus Infection and the Enigma of Maternal Immunity. J. Virol., 91.","DOI":"10.1128\/JVI.02392-16"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"S182","DOI":"10.1093\/cid\/cit609","article-title":"Congenital cytomegalovirus infection: Audiologic outcome","volume":"57","author":"Fowler","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/INF.0b013e31822d9640","article-title":"Congenital cytomegalovirus infection as a cause of sensorineural hearing loss in a highly immune population","volume":"30","author":"Yamamoto","year":"2011","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000096156","article-title":"Audiological outcome of infants with congenital cytomegalovirus infection in a prospective study","volume":"12","author":"Iwasaki","year":"2007","journal-title":"Audiol. Neurootol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e20162610","DOI":"10.1542\/peds.2016-2610","article-title":"Hearing Loss in Children With Asymptomatic Congenital Cytomegalovirus Infection","volume":"139","author":"Lanzieri","year":"2017","journal-title":"Pediatrics"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMra050700","article-title":"Newborn hearing screening\u2014A silent revolution","volume":"354","author":"Morton","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1001\/jama.1986.03380140074025","article-title":"Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome","volume":"256","author":"Stagno","year":"1986","journal-title":"JAMA"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/cid\/ciu096","article-title":"Birth prevalence of congenital cytomegalovirus among infants of HIV-infected women on prenatal antiretroviral prophylaxis in South Africa","volume":"58","author":"Manicklal","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/cid\/cit766","article-title":"High rates of congenital cytomegalovirus infection linked with maternal HIV infection among neonatal admissions at a large referral center in sub-Saharan Africa","volume":"58","author":"Mwaanza","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/cid\/cix222","article-title":"Cytomegalovirus Urinary Shedding in HIV-infected Pregnant Women and Congenital Cytomegalovirus Infection","volume":"65","author":"Adachi","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jcv.2011.07.005","article-title":"Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age","volume":"52","author":"Enders","year":"2011","journal-title":"J. Clin. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jcv.2017.03.004","article-title":"Presence of Cytomegalovirus in urine and blood of pregnant women with primary infection might be associated with fetal infection","volume":"90","author":"Delforge","year":"2017","journal-title":"J. Clin. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000477168","article-title":"Perinatal Outcomes of Non-Primary Maternal Cytomegalovirus Infection: A 15-Year Experience","volume":"43","author":"Simonazzi","year":"2018","journal-title":"Fetal Diagn. Ther."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Mele, F., Fornara, C., Jarrossay, D., Furione, M., Arossa, A., Spinillo, A., Lanzavecchia, A., Gerna, G., Sallusto, F., and Lilleri, D. (2017). Phenotype and specificity of T cells in primary human cytomegalovirus infection during pregnancy: IL-7Rpos long-term memory phenotype is associated with protection from vertical transmission. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0187731"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jcv.2016.05.007","article-title":"Neutralizing and ELISA IgG antibodies to human cytomegalovirus glycoprotein complexes may help date the onset of primary infection in pregnancy","volume":"81","author":"Lilleri","year":"2016","journal-title":"J. Clin. Virol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/cid\/cix337","article-title":"Risk Factors for Congenital Cytomegalovirus Infection Following Primary and Nonprimary Maternal Infection: A Prospective Neonatal Screening Study Using Polymerase Chain Reaction in Saliva","volume":"65","author":"Magny","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/cid\/cix621","article-title":"Universal Screening With Use of Immunoglobulin G Avidity for Congenital Cytomegalovirus Infection","volume":"65","author":"Tanimura","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/00365548409087131","article-title":"Congenital cytomegalovirus infection and disease in Sweden and the relative importance of primary and secondary maternal infections","volume":"16","author":"Ahlfors","year":"1984","journal-title":"Scand. J. Infect. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1093\/cid\/ciq085","article-title":"Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection","volume":"52","author":"Wang","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/00365549950163969","article-title":"Report on a long-term study of maternal and congenital cytomegalovirus infection in Sweden. Review of prospective studies available in the literature","volume":"31","author":"Ahlfors","year":"1999","journal-title":"Scand. J. Infect. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/cid\/cit018","article-title":"Long-term outcomes of congenital cytomegalovirus infection in Sweden and the United Kingdom","volume":"56","author":"Townsend","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/INF.0b013e3181723d55","article-title":"Congenital cytomegalovirus infection in a highly seropositive semi-urban population in India","volume":"27","author":"Dar","year":"2008","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1542\/peds.104.1.55","article-title":"Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus","volume":"104","author":"Boppana","year":"1999","journal-title":"Pediatrics"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1056\/NEJM200105033441804","article-title":"Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity","volume":"344","author":"Boppana","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jpeds.2005.09.003","article-title":"Hearing loss in children with congenital cytomegalovirus infection born to mothers with preexisting immunity","volume":"148","author":"Ross","year":"2006","journal-title":"J. Pediatr."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"297.e1","DOI":"10.1016\/j.ajog.2009.11.018","article-title":"Human cytomegalovirus reinfection is associated with intrauterine transmission in a highly cytomegalovirus-immune maternal population","volume":"202","author":"Yamamoto","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1542\/peds.107.5.1227","article-title":"Secondary maternal cytomegalovirus infection\u2014A significant cause of congenital disease","volume":"107","author":"Ahlfors","year":"2001","journal-title":"Pediatrics"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJM199203053261003","article-title":"The outcome of congenital cytomegalovirus infection in relation to maternal antibody status","volume":"326","author":"Fowler","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/infdis\/139.6.728","article-title":"Summary of a workshop on cytomegalovirus infections during organ transplantation","volume":"139","author":"Rubin","year":"1979","journal-title":"J. Infect. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1126\/science.277.5322.112","article-title":"Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease","volume":"277","author":"Autran","year":"1997","journal-title":"Science"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nm0898-953","article-title":"Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1","volume":"4","author":"Komanduri","year":"1998","journal-title":"Nat. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1086\/427828","article-title":"Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease","volume":"191","author":"Bronke","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1111\/j.1600-6143.2011.03636.x","article-title":"Virologic and immunologic monitoring of cytomegalovirus to guide preemptive therapy in solid-organ transplantation","volume":"11","author":"Gerna","year":"2011","journal-title":"Am. J. Transplant."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1182\/blood-2010-03-273508","article-title":"Immune monitoring with iT Ag MHC tetramers for prediction of recurrent or persistent cytomegalovirus infection or disease in allogeneic hematopoietic stem cell transplant recipients: A prospective multicenter study","volume":"116","author":"Gratama","year":"2010","journal-title":"Blood"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1093\/cid\/ciu589","article-title":"Preformed frequencies of cytomegalovirus (CMV)-specific memory T and B cells identify protected CMV-sensitized individuals among seronegative kidney transplant recipients","volume":"59","author":"Lucia","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/sj.bmt.1705585","article-title":"Patients at high risk for CMV infection and disease show delayed CD8+ T-cell immune recovery after allogeneic stem cell transplantation","volume":"39","author":"Ganepola","year":"2007","journal-title":"Bone Marrow Transpl."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1182\/blood.V78.5.1373.1373","article-title":"Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: Pattern of recovery and correlation with cytomegalovirus infection and disease","volume":"78","author":"Reusser","year":"1991","journal-title":"Blood"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood.V83.7.1971.1971","article-title":"Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: Correlation with CMV disease and effect of ganciclovir prophylaxis","volume":"83","author":"Li","year":"1994","journal-title":"Blood"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1093\/cid\/cis818","article-title":"State-of-the-art monitoring of cytomegalovirus-specific cell-mediated immunity after organ transplant: A primer for the clinician","volume":"55","author":"Egli","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1016\/j.bbmt.2015.08.002","article-title":"Reconstitution of Human Cytomegalovirus-Specific CD4+ T Cells is Critical for Control of Virus Reactivation in Hematopoietic Stem Cell Transplant Recipients but Does Not Prevent Organ Infection","volume":"21","author":"Gabanti","year":"2015","journal-title":"Biol. Blood Marrow Transpl."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM199510193331603","article-title":"Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor","volume":"333","author":"Walter","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1056\/NEJM198710223171703","article-title":"Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients","volume":"317","author":"Snydman","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1399-0012.1997.tb00847.x","article-title":"Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group","volume":"11","author":"Falagas","year":"1997","journal-title":"Clin. Transplant."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7326\/0003-4819-123-1-199507010-00002","article-title":"Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial","volume":"123","author":"Hibberd","year":"1995","journal-title":"Ann. Intern. Med."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Ishida, J.H., Patel, A., Mehta, A.K., Gatault, P., McBride, J.M., Burgess, T., Derby, M.A., Snydman, D.R., Emu, B., and Feierbach, B. (2017). Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients. Antimicrob. Agents Chemother., 61.","DOI":"10.1128\/AAC.01794-16"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJM198906293202605","article-title":"Severe herpesvirus infections in an adolescent without natural killer cells","volume":"320","author":"Biron","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00430-015-0406-1","article-title":"Exploiting viral natural history for vaccine development","volume":"204","author":"Barry","year":"2015","journal-title":"Med. Microbiol. Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.3390\/v6041483","article-title":"Using the nonhuman primate model of HCMV to guide vaccine development","volume":"6","author":"Deere","year":"2014","journal-title":"Viruses"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1128\/JVI.01669-12","article-title":"A vaccine based on the rhesus cytomegalovirus UL128 complex induces broadly neutralizing antibodies in rhesus macaques","volume":"87","author":"Wussow","year":"2013","journal-title":"J. Virol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1128\/JVI.00883-10","article-title":"Vaccine-induced control of viral shedding following rhesus cytomegalovirus challenge in rhesus macaques","volume":"85","author":"Abel","year":"2011","journal-title":"J. Virol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.vaccine.2013.09.042","article-title":"Priorities for CMV vaccine development","volume":"32","author":"Krause","year":"2013","journal-title":"Vaccine"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1111\/ajt.13188","article-title":"Rat Cytomegalovirus Vaccine Prevents Accelerated Chronic Rejection in CMV-Naive Recipients of Infected Donor Allograft Hearts","volume":"15","author":"Streblow","year":"2015","journal-title":"Am. J. Transpl."},{"key":"ref_74","unstructured":"Brizic, I., Hirsl, L., Britt, W.J., Krmpotic, A., and Jonjic, S. (2017). Immune responses to congenital cytomegalovirus infection. Microbes Infect."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1172\/JCI43961","article-title":"Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties","volume":"120","author":"Slavuljica","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"6584","DOI":"10.1128\/JVI.75.14.6584-6600.2001","article-title":"Experimental preemptive immunotherapy of murine cytomegalovirus disease with CD8 T-cell lines specific for ppM83 and pM84, the two homologs of human cytomegalovirus tegument protein ppUL83 (pp65)","volume":"75","author":"Holtappels","year":"2001","journal-title":"J. Virol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00430-008-0093-2","article-title":"CD8 T-cell-based immunotherapy of cytomegalovirus infection: \u201cproof of concept\u201d provided by the murine model","volume":"197","author":"Holtappels","year":"2008","journal-title":"Med. Microbiol. Immunol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"7496","DOI":"10.1128\/JVI.74.16.7496-7507.2000","article-title":"Murine model of interstitial cytomegalovirus pneumona in syngenic bone marrow transplantation: Persistence of protective pulmonary CD8-T-cell infiltrates after clearance of acute infection","volume":"74","author":"Podlech","year":"2000","journal-title":"J. Virol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"7661","DOI":"10.1128\/JVI.76.15.7661-7671.2002","article-title":"Experimental coinfection of rhesus macaques with rhesus cytomegalovirus and simian immunodeficiency virus: Pathogenesis","volume":"76","author":"Sequar","year":"2002","journal-title":"J. Virol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature12519","article-title":"Immune clearance of highly pathogenic SIV infection","volume":"502","author":"Hansen","year":"2013","journal-title":"Nature"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nm.4473","article-title":"Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine","volume":"24","author":"Hansen","year":"2018","journal-title":"Nat. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1743-422X-4-26","article-title":"Transplacental murine cytomegalovirus infection in the brain of SCID mice","volume":"4","author":"Woolf","year":"2007","journal-title":"Virol. J."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"13645","DOI":"10.1073\/pnas.1511526112","article-title":"Maternal CD4+ T cells protect against severe congenital cytomegalovirus disease in a novel nonhuman primate model of placental cytomegalovirus transmission","volume":"112","author":"Bialas","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_84","first-page":"112","article-title":"Inbred guinea pig model of intrauterine infection with cytomegalovirus","volume":"122","author":"Griffith","year":"1986","journal-title":"Am. J. Pathol."},{"key":"ref_85","first-page":"233","article-title":"The guinea pig cytomegalovirus model of congenital human cytomegalovirus infection","volume":"20","author":"Bia","year":"1984","journal-title":"Birth Defects"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/infdis\/172.5.1212","article-title":"Reduced congenital cytomegalovirus (CMV) infection after maternal immunization with a guinea pig CMV glycoprotein before gestational primary CMV infection in the guinea pig model","volume":"172","author":"Harrison","year":"1995","journal-title":"J. Infect. Dis."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"7902","DOI":"10.1128\/JVI.00283-16","article-title":"A Novel Non-Replication-Competent Cytomegalovirus Capsid Mutant Vaccine Strategy Is Effective in Reducing Congenital Infection","volume":"90","author":"Choi","year":"2016","journal-title":"J. Virol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e00300-16","DOI":"10.1128\/CVI.00300-16","article-title":"Additive Protection against Congenital Cytomegalovirus Conferred by Combined Glycoprotein B\/pp65 Vaccination Using a Lymphocytic Choriomeningitis Virus Vector","volume":"24","author":"Schleiss","year":"2017","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1016\/j.vaccine.2015.06.019","article-title":"Comparison of monovalent glycoprotein B with bivalent gB\/pp65 (GP83) vaccine for congenital cytomegalovirus infection in a guinea pig model: Inclusion of GP83 reduces gB antibody response but both vaccine approaches provide equivalent protection against pup mortality","volume":"33","author":"Swanson","year":"2015","journal-title":"Vaccine"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1086\/317654","article-title":"Preconception immunization with a cytomegalovirus (CMV) glycoprotein vaccine improves pregnancy outcome in a guniea pig model of congenital CMV infection","volume":"183","author":"Borune","year":"2001","journal-title":"J. Infect. Dis."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1086\/382751","article-title":"Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine","volume":"189","author":"Schleiss","year":"2004","journal-title":"J. Infect. Dis."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Auerbach, M.R., Yan, D., Vij, R., Hongo, J.A., Nakamura, G., Vernes, J.M., Meng, Y.G., Lein, S., Chan, P., and Ross, J. (2014). A neutralizing anti-gH\/gL monoclonal antibody is protective in the guinea pig model of congenital CMV infection. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004060"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/infdis\/172.4.944","article-title":"Effect of passive antibody on congenital cytomegalovirus infection in guinea pigs","volume":"172","author":"Bratcher","year":"1995","journal-title":"J. Infect. Dis."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1086\/320714","article-title":"Modification of maternal and congenital cytomegalovirus infection by anti-glycoprotein b antibody transfer in guinea pigs","volume":"183","author":"Chatterjee","year":"2001","journal-title":"J. Infect. Dis."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1016\/j.vaccine.2013.04.078","article-title":"Effects of immunization of pregnant guinea pigs with guinea pig cytomegalovirus glycoprotein B on viral spread in the placenta","volume":"31","author":"Hashimoto","year":"2013","journal-title":"Vaccine"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJMoa1310214","article-title":"A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus","volume":"370","author":"Revello","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Blazquez-Gamero, D., Galindo Izquierdo, A., Del Rosal, T., Baquero-Artigao, F., Izquierdo Mendez, N., Soriano-Ramos, M., Rojo Conejo, P., Gonzalez-Tome, M.I., Garcia-Burguillo, A., and Perez Perez, N. (2017). Prevention and treatment of fetal cytomegalovirus infection with cytomegalovirus hyperimmune globulin: A multicenter study in Madrid. J. Matern. Fetal Neonatal Med., 1\u20139.","DOI":"10.1080\/14767058.2017.1387890"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Kagan, K.O., Enders, M., Schampera, M.S., Baeumel, E., Hoopmann, M., Geipel, A., Berg, C., Goelz, R., de Catte, L., and Wallwiener, D. (2018). Prevention of maternal-fetal transmission of CMV by hyperimmunoglobulin (HIG) administered after a primary maternal CMV infectionin early gestation. Ultrasound Obstet. Gynecol.","DOI":"10.1055\/s-0038-1671626"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/infdis\/158.5.917","article-title":"Primary cytomegalovirus infection in pregnancy: Comparison of antibody responses to virus-encoded proteins between women with and without intrauterine infection","volume":"158","author":"Alford","year":"1988","journal-title":"J. Infect. Dis."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Lilleri, D., Kabanova, A., Revello, M.G., Percivalle, E., Sarasini, A., Genini, E., Sallusto, F., Lanzavecchia, A., Corti, D., and Gerna, G. (2013). Fetal human cytomegalovirus transmission correlates with delayed maternal antibodies to gH\/gL\/pUL128\u2013130\u2013131 complex during primary infection. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0059863"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/infdis\/171.5.1115","article-title":"Antiviral antibody responses and intrauterine transmission after primary maternal cytomegalovirus infection","volume":"171","author":"Boppana","year":"1995","journal-title":"J. Infect. Dis."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Lilleri, D., and Gerna, G. (2017). Maternal immune correlates of protection from human cytomegalovirus transmission to the fetus after primary infection in pregnancy. Rev. Med. Virol., 27.","DOI":"10.1002\/rmv.1921"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1002\/jmv.23691","article-title":"Slow increase in IgG avidity correlates with prevention of human cytomegalovirus transmission to the fetus","volume":"85","author":"Furione","year":"2013","journal-title":"J. Med. Virol."},{"key":"ref_104","unstructured":"Johnson, D., Vanarsdall, A., Chin, A., Jardetzky, T., and Liu, J. (2018, January 21\u201325). Similar Levels of HCMV Pentamer- and Trimer-Specific Neutralizing Antibodies in Human Sera from Transplant Patients and Mothers and Neither Predict Outcome. Proceedings of the International Herpesvirus Workshop, Vancouver, BC, Canada."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1086\/512245","article-title":"Development of human cytomegalovirus-specific T cell immunity during primary infection of pregnant women and its correlation with virus transmission to the fetus","volume":"195","author":"Lilleri","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1093\/cid\/cix622","article-title":"Human Cytomegalovirus-Specific Memory CD4+ T-Cell Response and Its Correlation With Virus Transmission to the Fetus in Pregnant Women With Primary Infection","volume":"65","author":"Fornara","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1128\/JCM.00561-16","article-title":"Cytomegalovirus (CMV) Enzyme-Linked Immunosorbent Spot Assay but Not CMV QuantiFERON Assay Is a Novel Biomarker To Determine Risk of Congenital CMV Infection in Pregnant Women","volume":"54","author":"Forner","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1056\/NEJM198204223061601","article-title":"Congenital cytomegalovirus infection: The relative importance of primary and recurrent maternal infection","volume":"306","author":"Stagno","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1542\/peds.73.2.188","article-title":"Reasons for the absence of a history of recurrent genital infections in mothers of neonates infected with herpes simplex virus","volume":"73","author":"Yeager","year":"1984","journal-title":"Pediatrics"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Bootz, A., Karbach, A., Spindler, J., Kropff, B., Reuter, N., Sticht, H., Winkler, T.H., Britt, W.J., and Mach, M. (2017). Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006601"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Nelson, C.S., Cruz, D.V., Tran, D., Bialas, K.M., Stamper, L., Wu, H., Gilbert, M., Blair, R., Alvarez, X., and Itell, H. (2017). Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeys. JCI Insight, 2.","DOI":"10.1172\/jci.insight.94002"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0166-3542(03)00151-7","article-title":"An animal model of neonatal cytomegalovirus infection","volume":"60","author":"Bravo","year":"2003","journal-title":"Antiviral Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/infdis\/171.1.26","article-title":"Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age","volume":"171","author":"Adler","year":"1995","journal-title":"J. Infect. Dis."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa0804749","article-title":"Vaccine prevention of maternal cytomegalovirus infection","volume":"360","author":"Pass","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1093\/infdis\/jir138","article-title":"Glycoprotein B vaccine is capable of boosting both antibody and CD4 T-cell responses to cytomegalovirus in chronically infected women","volume":"203","author":"Sabbaj","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.vaccine.2015.11.056","article-title":"Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial","volume":"34","author":"Bernstein","year":"2016","journal-title":"Vaccine"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1073\/pnas.1800177115","article-title":"HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions","volume":"115","author":"Nelson","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1128\/jvi.65.1.138-146.1991","article-title":"Distribution of linear antigenic sites on glycoprotein gp55 of human cytomegalovirus","volume":"65","author":"Kneiss","year":"1991","journal-title":"J. Virol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/infdis\/169.1.83","article-title":"Epitope-specific distribution of IgG subclasses against antigenic domains on glycoproteins of human cytomegalovirus","volume":"169","author":"Urban","year":"1994","journal-title":"J. Infect. Dis."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/10\/8\/405\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:16:18Z","timestamp":1760195778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/10\/8\/405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,3]]},"references-count":119,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,8]]}},"alternative-id":["v10080405"],"URL":"https:\/\/doi.org\/10.3390\/v10080405","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,3]]}}}